Feedback / Questions
Deltacel (KB-GDT-01) - Kiromic
https://www.businesswire.com/news/home/20240424199583/en/Kiromic-BioPharma-Reports-Consistent-Favorable-Safety-Tolerability-and-Efficacy-in-Deltacel-01-Clinical-Trial-First-Three-Patients
Apr 24, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next